Assessment of teratogenic risk

Area of Science:

• Obstetrics and Gynecology
• Pharmacology
• Pediatrics

Background:

• The teratogenic risks of older antiepileptic drugs (AEDs) during pregnancy are not fully understood.
• Specific AEDs, combinations, dosages, and their teratogenic patterns remain unclear.
• Data on the safety of newer generation AEDs in pregnancy is lacking.

Purpose of the Study:

• To highlight the limitations of current research on AEDs and congenital malformations.
• To emphasize the need for large-scale prospective studies and international registries.
• To define essential components for high-quality data collection and analysis.

Main Methods:

• The study emphasizes the need for large prospective international registries.
• Recommends pre-defined data collection modalities with common, exhaustive, yet feasible protocols.
• Advocates for detailed information on malformations, growth retardation, and confounding factors.

Main Results:

• Current studies are limited by insufficient sample sizes.
• Existing research cannot definitively link specific AEDs or dosages to particular malformations.
• The teratogenic potential of newer AEDs remains largely unknown.

Conclusions:

• Large-scale international registries are essential for robust teratogenic risk assessment of AEDs.
• Standardized data collection protocols are crucial for comparative analysis.
• High-quality data, including prolonged follow-up, is necessary to accurately evaluate AEDs' safety in pregnancy.